Likewise, changes in the expression levels of both CLDND1 and MUC1 are associated with the development of lung cancer; it would be interesting to assess the performance of the gene expression model in subjects with other smoking-related diseases such as lung cancer, asthma, and COPD. Here, CLDND1 is linked to lung carcinoma.